Grant opportunity · PAR-25-175
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Who can apply (as listed)
- Native American tribal organizations (other than federally recognized governments)
- Public housing authorities / Indian housing authorities
- State governments
- Public and state-controlled institutions of higher education
- Nonprofits without 501(c)(3) status (other than institutions of higher education)
- City or township governments
- For-profit organizations (other than small businesses)
- Special district governments
- Native American tribal governments (federally recognized)
- Nonprofits with 501(c)(3) status (other than institutions of higher education)
- Others (see the opportunity text)
- Independent school districts
- County governments
- Small businesses
- Private institutions of higher education
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance.
Excerpt as published. The full synopsis, required forms, and any amendments are on the official listing.
GrantSet indexes public records and is not the official application channel. Responses and applications go through Grants.gov only — the official notice there controls if anything shown here differs.